The global liquid biopsy market is expected to reach $4,380.534 million by 2024 from $1,246.248 million in 2018 growing at a CAGR of 23.31%. Liquid biopsy, also known as fluid biopsy is a non-invasive technique which enables to discover a range of information about a tumour through sampling and analysis of non-solid biological tissue such as blood. The evolution of sensitive technologies have enabled the development of liquid biopsies for various clinical applications including screening Read more...
The global biologics market is expected to reach US$310.776 billion by 2023 from US$236.121 billion in 2017 growing at a CAGR of 4.69%. Biologics or biologic drug is a produced from living organisms or contain components of living organisms. They can be derived from human, animal, or microorganisms by using biotechnological techniques. Biologics consists of products such as vaccines, blood and blood components, allergenics, somatic cells, gene therapy, tissues, and recombinant therapeutic protei Read more...
The global biobetter market is projected to grow at a CAGR of 30.64% to reach US$64.041 billion by 2024, from US$12.884 billion in 2018. The low development cost of biobetters as compared to the biologics will augment the market growth during the given forecast period. Biobetters are improved versions of originator biologics which are similar to existing biologics entities by action, potency and by other factors. Biobetters are formed as a result of chemical modification, protein fusion, alter Read more...
The global pharmaceutical excipients market is expected to reach US$7.790 billion by 2023 from US$5.181 billion in 2017 growing at a CAGR of 7.03%. Excipients are the pharmacologically inactive substances added along with the active drug substance to streamline the manufacture of the drug product and aid in lubricity, flowability, disintegration, taste and may confer some form of antimicrobial function, also facilitating physiological absorption of the drug. Some of the excipients used in pharma Read more...
The global research antibodies market is projected to grow at a CAGR of XX%, increasing from US$ XX billion in 2017 to US$ XX billion in 2023. Research antibodies react to the presence of specific antibody make them indispensable tool for the clinical as well as basic researches. Due to the high specificity and selectivity of the antibodies, they are being used in wide variety of applications such as biochemical tools for a range of applications including selection, identification, purification Read more...
Cryogenic tank market is projected to grow at a CAGR of 6.59% to reach US$2,123.838 million by 2024, from US$1,448.108 million in 2018. Cryogenic tanks are used to store and transport liquefied gases such as liquid oxygen, liquefied natural gas (LNG), and liquid nitrogen. These gases are stored at extremely high pressures and low temperatures. High demand for these gases across different industries including pharmaceuticals, petrochemical, and food and beverage is fueling the demand for cryoge Read more...
The global immunoassay market is projected to grow at a CAGR of 7.15% during the forecast period of 2017-2023. Immunoassays are bioanalytical methods that capitalizes on the specificity of the antibody-antigen binding found naturally in the immune system and are highly sensitive and specific. Immunoassay methods are capable of quantifying wide variety of compounds such as low molecular weight drugs, macromolecular biomolecules, and biomarkers which indicate disease diagnosis or prognosis. These Read more...
The global biosimilar market is estimated to register a CAGR of 40.14% over the forecast period of to reach a market size of US$19.151 billion by 2023 from US$2.528 billion in 2017. Biosimilars are defined as the licensed and highly similar version of biologic drugs that have already been approved for use by the regulatory bodies. The growth in the market may be attributed to the cost-effectiveness of the biosimilars when compared to reference biologics coupled with the patent expiration of the Read more...
The global organoid technology market is projected to grow at a CAGR of 28.11% during the forecast period. Organoid technology refers to the growing of organs or ‘mini-organs’ under lab conditions. It is also referred to as 3D cell culture technology which leads to organ formation useful to replace, repair or regenerate any diseased tissue or organs and holds a promising future in cancer and biomedical research. Read more...
The global RNA sequencing (RNA-Seq) market is projected to witness a significant growth rate during the forecast period, growing at a CAGR of 12.07% during the forecast period to reach a total market size of US$3.692 billion by 2022, increasing from US$1.863 billion in 2016. Viral evolution and increasing incidence of genetic disorders have elevated the need for technical advancements in RNA sequencing products which are expected to drive the market over the projected period. Increasing grants f Read more...
.jpg)
